JAY S. SKYLER

Insider Reports History

Location
Brisbane, CA
Signature
/s/ Jay S. Skyler
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JAY S. SKYLER:

Company Role Class Num Shares Value Price $ Report Date Ownership
DEXCOM INC Director Common Stock 63,348 $7,832,017 $123.63 18 May 2023 by Partnership
DEXCOM INC Director Common Stock 40,000 $4,945,392 $123.63 18 May 2023 by Spouse
Applied Therapeutics, Inc. Director Stock Option (Right to Buy) 200,000 09 Jun 2025 Direct
SAB Biotherapeutics, Inc. Director Stock Option (right to buy) 150,000 16 Dec 2025 Direct
DEXCOM INC Director Common Stock 0 $123.63 18 May 2023 Direct

Insider Reports Filed by JAY S. SKYLER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SABS SAB Biotherapeutics, Inc. 16 Dec 2025 1 $0 4 Director 18 Dec 2025, 16:55
APLT Applied Therapeutics, Inc. 09 Jun 2025 1 $0 4 Director 11 Jun 2025, 06:01
SABS SAB Biotherapeutics, Inc. 15 Jul 2024 2 $0 4 Director 17 Jul 2024, 16:30
APLT Applied Therapeutics, Inc. 06 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:13
SABS SAB Biotherapeutics, Inc. 03 May 2024 0 $0 3 Director 14 May 2024, 17:00
APLT Applied Therapeutics Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 21:03
DXCM DEXCOM INC 18 May 2023 2 $0 4 Director 22 May 2023, 15:50
APLT Applied Therapeutics Inc. 02 Aug 2022 8 $0 4 Director 04 Aug 2022, 20:41
APLT Applied Therapeutics Inc. 03 Jun 2022 1 $0 4 Director 07 Jun 2022, 21:21
DXCM DEXCOM INC 20 May 2022 3 +$0.969 4 Director 23 May 2022, 17:07
DXCM DEXCOM INC 22 Jun 2021 3 -$8,527,406 4 Director 24 Jun 2021, 17:59
APLT Applied Therapeutics Inc. 03 Jun 2021 1 $0 4 Director 04 Jun 2021, 19:19
DXCM DEXCOM INC 21 May 2021 3 +$0.9 4 Director 25 May 2021, 19:57